Lyo Controlled Ice Nucleation

Assessing Process Performance of Controlled Ice Nucleation

4K microstructure render of a DigiM pharmaceutical sample showing internal phase composition at high resolution
Full field-of-view pharmaceutical tablet microstructure image showing internal phase distribution and pore network

Analyzing the controlled ice nucleation process with a focus on the process performance and product attributes

What is controlled ice nucleation?

Lyophilization, or freeze-drying, has been around for centuries, dating back as far as the 13th century. However, in the past few decades there has been little change to process design, monitoring, and quality control assessment. Controlled ice nucleation (CIN) technology is a new method to improve efficiency in time and cost for lyophilization in addition to increasing batch homogeneity and product quality.

controlled ice nucleation CIN freeze drying lyophilization microporosity
Quantitative data gathered from XRM images using artificial intelligence to calculate the microporosity size of two samples processed at different temperatures.

The technique involves cooling the batch to a specific temperature in order to reduce the randomness that ice generation can bring to a lyophilized sample such as ice crystal size and distribution. DigiM’s non-invasive X-ray imaging has been used to improve the understanding of the relationships between CIN process parameters and performance with product quality attributes. With AI technology, microstructure quality attributes including microporosity and cake wall thickness can be directly quantified.

AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo

Our Expertise

In Numbers

95
+
%

Programs Supported

981
+
%

Formulations Digitized

22
+
%

Pharmaceutical Partners

Stats section background image for DigiM Solution website showing pharmaceutical data visualization context

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

Purple tablet dispersing into a fine particle cloud, illustrating drug microstructure disintegration